HER2‐Targeted Antibody–Drug Conjugates–Associated Interstitial Lung Disease: A Pharmacovigilance Study Based on FDA Adverse Event Reporting System Data.
Saved in:
| Title: | HER2‐Targeted Antibody–Drug Conjugates–Associated Interstitial Lung Disease: A Pharmacovigilance Study Based on FDA Adverse Event Reporting System Data. |
|---|---|
| Authors: | Du, Di1 (AUTHOR), Zhu, Yanna2 (AUTHOR), Zheng, Hongmei3 (AUTHOR), Xu, Suying1 (AUTHOR), Li, Yuke1 (AUTHOR), Zhan, Peng3 (AUTHOR), Yang, Jun4 (AUTHOR), Wang, Yanting4 (AUTHOR) yanting.wang@cicams.ac.cn, Liu, Hongda (AUTHOR) liuhongda@njmu.edu.cn |
| Source: | Journal of Clinical Pharmacy & Therapeutics. 6/13/2026, Vol. 2026, p1-12. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 02694727 |
|---|---|
| DOI: | 10.1155/jcpt/7121390 |
